Skip to main content

Advertisement

Table 1 Characteristics overall and for men and women

From: Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans

Variables Men (157) Women (151) P-value Total (308)
Mean age, years (SD) 55.6 (10.1) 56 (10.9) 0.74 55.8 (10.5)
Known duration of diabetes* 3.0 (0.5-5.0) 3.0 (0.5-5.0) 0.46 3.0 (0.5-5.0)
Mean BMI, kg/m2 (SD) 27.0 (4.2) 28.8 (5.0) <0.001 27.9 (4.7)
Mean waist circumference, cm (SD) 95.9 (9.6) 97.4 (11.0) 0.20 96.6 (10.4)
Mean systolic blood pressure, mm Hg (SD) 142.9 (24.5) 142.8 (25.2) 0.95 142.7 (24.8)
Mean diastolic blood pressure, mm Hg (SD) 84.3 (11.9) 83.0 (11.8) 0.37 83.7 (11.9)
Hypertension, n (%) 84 (53.5%) 83 (55%) 0.80 167 (54.2%)
Smoking, n (%) 13 (8.3%) 2 (1.3%) 0.003 15 (4.9%)
Mean total cholesterol, g/L (SD) 1.78 (0.56) 1.80 (0.52) 0.79 1.79 (0.54)
Mean LDL cholesterol, g/L (SD) 1.10 (0.53) 1.12 (0.49) 0.69 1.11 (0.51)
Mean HDL cholesterol, g/L (SD) 0.53 (0.21) 0.58 (0.22) 0.04 0.56 (0.22)
Triglycerides (g/l)* 0.92 (0.65-1.25) 0.84 (0.58-1.26) 0.41 0.88 (0.63-1.26)
Mean fasting glucose, g/L (SD) 1.57 (0.64) 1.48 (0.61) 0.25 1.53 (0.62)
Mean post-prandial glucose, g/l (SD) 1.96 (0.86) 1.78 (0.81) 0.04 1.87 (0.84)
Glucose control treatments     
Oral agents, n (%) 114 (72.6%) 108 (71.5%) 0.83 222 (72.1%)
Insulin, n (%) 32 (20.4%) 46 (30.5%) 0.04 78 (25.3%)
Insulin and Oral agents, n (%) 8 (5.1%) 18 (11.9%) 0.04 26 (8.4%)
Blood pressure lowering medications, n (%) 65 (41.4%) 73 (48.3%) 0.22 138 (44.8%)
Statins use, n (%) 2 (1.3%) 1 (0.7%) 0.58 3 (1%)
Aspirin use, n (%) 2 (1.3%) 2 (1.3%) > 0.99 4 (1.3%)
  1. * Values are Median (25th – 75th percentiles).